Kamada Ltd. To Present At The Oppenheimer 26th Annual Healthcare Conference

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that Company management will participate at the Oppenheimer 26th Annual Healthcare Conference being held from December 8-9, 2015 at the Westin Grand Central Hotel in New York City. Gil Efron, Kamada’s Deputy Chief Executive Officer and Chief Financial Officer, will present a corporate overview and update on December 9, 2015 at 3:15 p.m. Eastern Time.